Skip to content

Clinical trials

Phase 1 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 1 Clear all

527 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20044
20055
200613
200733
200835
200939
201028
201117
201219
201322
201421
201529
201627
201718
201823
201926
202022
202127
202221
202321
202424
202522
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed375
Terminated52
Recruiting38
Unknown status18
Not yet recruiting18
Active, not recruiting16
Withdrawn8
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wyeth is now a wholly owned subsidiary of Pfizer28
Pfizer22
Eli Lilly and Company20
Institute for Neurodegenerative Disorders18
Merck Sharp & Dohme LLC18
Avid Radiopharmaceuticals14
GlaxoSmithKline14
AstraZeneca13
Bristol-Myers Squibb12
Janssen Research & Development, LLC11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease527
Cognitive Dysfunction54
Dementia38
Parkinson Disease17
Neurodegenerative Diseases14
Tauopathies11
Huntington Disease10
Plaque, Amyloid10
Supranuclear Palsy, Progressive9
Central Nervous System Diseases8

Trials

Showing 26 to 50 of 527. Each trial links to its page on Pharma Observatory.

427 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.